Unani treatment for Heavy Menstrual Bleeding

Effect of Qurs-i-Shibb in Kathrat-i-Tamth (HMB): An observational clinical study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023357

Enrollment

Registered

2020-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Qurs-i-shibb: Shibbe Yamani(Alum) 10.5 gram Damul Akhwain Dracaena cinnabari Balf.f.) 10.5 gram Gulnar (Punica granatum Linn.) 10.5gram Kateera(Coch

Eligibility

Inclusion criteria

Inclusion criteria: 1-Women between the ages of 18-40 Years. 2-Regular cycles with heavy bleeding in duration or amount of flow or both.

Exclusion criteria

Exclusion criteria: Patients with 1-Hb less than 8.5 gm%. 2-H/o systemic diseases and blood dyscrasia. 3-H/o of pelvic pathology and malignancy. 4-H/o of OCPs,IUCD insertion in last 3 months.

Design outcomes

Primary

Measure	Time frame
Decrease in Bleeding (amount/ duration)Timepoint: One and half year	—

Secondary

Measure	Time frame
Change in 1-PBAC Score(100) 2-SF12 scale to assess the QoLTimepoint: One and Half year	—

Countries

India

Contacts

Public ContactGhufran Najeeb

National Institute of Unani Medicine

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026